Literature DB >> 2612080

Estrogen receptor levels in a murine model of systemic lupus erythematosus.

B H Athreya1, W C Moore, S A Wadsworth, C Gupta, A S Goldman.   

Abstract

Offspring of a cross between the NZB and NZW mice (F1) develop a disease similar to SLE in humans. Female mice of the F1 strain develop the disease at a younger age and die earlier than the males. In order to test the hypothesis that estrogen receptor concentrations in the lymphoid organs of these mice may correlate with increased female susceptibility, estrogen receptor assays were performed on cytosol from the uterus, thymus, spleen, and liver of affected animals and the parental stock using the dextran-charcoal method. Specific binding of the receptor was analysed by Scatchard analysis. There were no differences among receptor concentrations in the uterus, thymus, and spleen of NZB, NZW, and F1 mice. However, the estrogen receptor concentrations in the liver from NZW and F1 mice were twice that of NZB mice. This observation may be of importance since the liver is involved in steroid metabolism and abnormalities of estrogen metabolism have been reported in human SLE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612080

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus.

Authors:  Emily L Gilbert; Keisa W Mathis; Michael J Ryan
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

Review 2.  Estrogen in cardiovascular disease during systemic lupus erythematosus.

Authors:  Emily L Gilbert; Michael J Ryan
Journal:  Clin Ther       Date:  2014-09-04       Impact factor: 3.393

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.